Moderate and Severe CKD Market Expected to Reach USD 18.7 Billion by 2035, Growing at 3.3% CAGR

WiseGuy Reports, Nov. 2025 (Press Release) – Moderate and Severe Chronic Kidney Disease (CKD) Market Global Outlook:

Global Moderate and Severe Chronic Kidney Disease (CKD) Market Growth Research and Competitive Trends Analysis Report By Stage of Disease (Moderate Chronic Kidney Disease, Severe Chronic Kidney Disease), By Diagnosis Method (Blood Tests, Urine Tests, Imaging Tests, Kidney Biopsy), By Treatment Type (Medication, Dialysis, Kidney Transplant, Lifestyle Changes), By End User (Hospitals, Clinics, Home Care) and By Regional Size, Share, and Forecast to 2035

Moderate and Severe Chronic Kidney Disease (CKD) Market Accelerates as Aging Population and Diabetes Growth Drive Global Treatment Demand

The global Moderate and Severe Chronic Kidney Disease (CKD) Market continues to expand as chronic illnesses become more prevalent, diagnostic capabilities advance, and treatment options evolve. Chronic Kidney Disease, particularly in moderate and severe stages, requires extensive, long-term medical management, making it one of the largest healthcare burdens worldwide. According to recent market data, the Moderate and Severe Chronic Kidney Disease (CKD) Market Size reached USD 13.2 billion in 2024, is projected to grow to USD 13.6 billion in 2025, and is forecast to reach USD 18.7 billion by 2035, demonstrating a steady CAGR of 3.3% during the forecast period. Rising diabetes and hypertension cases, expanding healthcare expenditure, and increased awareness of early diagnosis are driving strong market growth across both developed and emerging economies. The global market economic outlook remains positive as governments and healthcare organizations emphasize preventive care and advanced CKD management solutions.

Competitive Landscape and Key Market Manufacturers

The Moderate and Severe Chronic Kidney Disease (CKD) Market includes pharmaceutical giants, dialysis service providers, biotechnology innovators, and medical device companies offering diagnostic and therapeutic solutions across the CKD care continuum. These organizations contribute significantly to market developments, research advancements, and innovative therapy expansions.

Key companies profiled include:

• DaVita Inc.
• Merck & Co.
• Gilead Sciences
• Johnson & Johnson
• Sanofi
• Pfizer Inc.
• Roche Holding AG
• Baxter International
• Regeneron Pharmaceuticals
• Fresenius Medical Care
• Eli Lilly and Company
• AbbVie Inc.
• AstraZeneca
• Amgen Inc.
• Boehringer Ingelheim
• These market top companies are investing heavily in R&D, biomarker innovations, advanced dialysis technologies, and personalized treatment options to strengthen their global presence and meet rising market demands.

Request To Free Sample of This Strategic Report –

https://www.wiseguyreports.com/sample-request?id=735925

Segmental Analysis

The Moderate and Severe Chronic Kidney Disease (CKD) Market is segmented by stage of disease, diagnosis method, treatment type, end user, and region.

Based on stage of disease, the market covers Stage 3, Stage 4, and Stage 5 CKD. Stage 3 contributes significantly due to higher patient population, while Stage 4 and Stage 5 are expanding rapidly as aging populations and diabetes rates continue to rise.

Under diagnosis method, the market includes blood tests, urine tests, imaging tests, glomerular filtration rate analysis, and biopsy procedures. Technological advancements in biomarker detection and imaging enable earlier detection, improving patient management and outcomes.

The treatment type segment includes medications, dialysis, lifestyle management, and supportive therapies. Dialysis continues to contribute a major market share, driven by increasing incidences of severe CKD, while drug therapies—such as ACE inhibitors, ARBs, SGLT2 inhibitors, erythropoiesis-stimulating agents, and phosphate binders—are experiencing strong growth due to ongoing product innovation.

In terms of end user, the market spans hospitals, specialty clinics, dialysis centers, and home healthcare settings. Home dialysis and telehealth-based CKD management solutions are gaining traction due to convenience and cost-effectiveness, driving new market trends and business models.

This segmentation highlights the evolving clinical landscape and underscores the importance of advanced diagnostic and treatment ecosystems supporting CKD care worldwide.

🛒 Buy Now Premium Research Report –

https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=735925

Regional Analysis

The Moderate and Severe Chronic Kidney Disease (CKD) Market covers North America, Europe, APAC, South America, and MEA, each contributing to strong global market regional share.

North America remains the leading region due to high diabetes prevalence, strong reimbursement systems, and advanced healthcare infrastructure. The United States dominates this region, supported by major CKD treatment providers, robust clinical research, and significant investments in dialysis technologies.

Europe, including Germany, the UK, France, and Italy, shows consistent growth due to increased screening programs, improved access to nephrology care, and rising awareness of chronic kidney conditions. Government-funded CKD prevention programs are boosting early diagnosis rates.

APAC represents the fastest-growing regional segment driven by large patient populations in India, China, and Southeast Asia. Rising obesity, diabetes, hypertension rates, and urban lifestyle changes are accelerating CKD incidence. Expanding healthcare spending and growing adoption of advanced diagnostic technologies contribute to strong market forecast potential.

South America, with Brazil and Argentina at the forefront, shows gradual growth due to healthcare modernization, higher CKD diagnosis rates, and increased adoption of dialysis services.

MEA is an emerging region with increasing CKD prevalence driven by genetic factors, diabetes, and limited preventive care. Improvements in healthcare infrastructure and medical technology access are enhancing diagnosis and treatment adoption.

Collectively, these regions demonstrate strong expansion opportunities for global and regional players, supported by healthcare modernization and rising demand for CKD management solutions.

Key Market Dynamics

The Moderate and Severe Chronic Kidney Disease (CKD) Market is driven by several critical market growth dynamics, including:

Aging population: As the global elderly population rises, CKD becomes increasingly prevalent due to natural kidney function decline.

Increasing diabetes prevalence: Diabetes remains the leading cause of CKD, significantly driving global market expansion.

Rising healthcare expenditure: Governments and private organizations are investing heavily in chronic disease management and CKD research.

Advancements in treatment options: Novel therapeutics, dialysis technologies, and personalized medicine approaches are driving improved outcomes.

Growing awareness and education: Public health initiatives and CKD education campaigns enhance early diagnosis and reduce disease progression rates.

These factors collectively influence strong market outlook, fueling widespread adoption of diagnostics and therapeutic solutions across regions.

Key Market Opportunities

Key opportunities within the Moderate and Severe Chronic Kidney Disease (CKD) Market include telehealth-based CKD monitoring, biomarker-driven diagnostics, minimally invasive treatment innovations, expanded patient support programs, and personalized therapies tailored to patient-specific disease progression.

KEY HIGHLIGHTS

• Market Size 2024: USD 13.2 Billion
• Market Size 2025: USD 13.6 Billion
• Market Size 2035: USD 18.7 Billion
• CAGR (2025–2035): 3.3%
• Segments: Stage of Disease, Diagnosis Method, Treatment Type, End User, Regional
• Key Drivers: Aging population, rising diabetes cases, advanced diagnostics, treatment innovation, global awareness
• Opportunities: Telehealth, biomarker research, enhanced diagnostics, personalized medicine, early detection programs

Browse Complete Premium Moderate and Severe Chronic Kidney Disease (CKD) Market Growth Research and Competitive Trends Analysis Report https://www.wiseguyreports.com/reports/moderate-and-severe-chronic-kidney-disease-ckd-market

Reasons To Buy the Digital Front Moderate and Severe Chronic Kidney Disease (CKD) Market Report:

➼ In-depth analysis of the Moderate and Severe Chronic Kidney Disease (CKD) Market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Related Research insights from Wise Guy Reports:

Cardiopulmonary Resuscitation CPR Machine Market

Binocular Optical Microscope Market

Handheld Pulse Oximeters Market

Medical Instrument Kits Market

Natural Dissolvable Sutures Market

Heated Humidifier Devices Market

Blood Separation System Market

Lancet Lancing Devices Market

Nano Surface Dental Implant Market

Smart Baby Monitor Market

About US:

Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation.